Outcome of Amarillo-related Botox trial should be interesting

People sometimes cry when I interview them.
I’m not proud to say that either.
Maybe their crying is a product of the story they’re telling. Maybe it’s a product of me and my harsh questions. I don’t know.
One such case of a mother crying came during an interview from July 2008.
Mother Dee Spears of Amarillo had lost her 7-year-old daughter less than a year before. She and several other families had filed a lawsuit against the makers of Botox, Irving, Calif.-based Allergan, for causing the death of her daughter. I was asking about the lawsuit and her daughter.
Daughter Kristen Spears suffered from cerebral palsy and began receiving Botox injections in June 2006 to treat her limb spasms, according to the lawsuit filed in Orange County Superior Court in California.
After a series of injections, the child developed pneumonia, her seizures worsened and she developed muscle weakness in her neck that prevented her from holding up her head, according to the suit. She died Nov. 24, 2007.
Jury selection began today in California in the trial of Spears and Allergan.
It’s curious that Allergan didn’t settle the case already.
The pharmaceutical giant profited $3.5 billion in 2008. Its revenue exceeded $4.4 billion. That’s a lot of dough.
Usually the cost of litigation exceeds whatever of a settlement, and defendants rather cut a check than stand trial.
Allergan probably thinks it can win a case against Spears.
The trial may take a few weeks, but we’ll see what the outcome is.